Insulin Lispro Protamine Recombinant; Insulin Lispro Recombinant Patent Expiration

1. Humalog Mix 50/50 patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5514646 LILLY Insulin analogs modified at position 29 of the B chain
May, 2013

(11 years ago)

US5474978 LILLY Insulin analog formulations
Jun, 2014

(10 years ago)

US5461031 LILLY Monomeric insulin analog formulations
Jun, 2014

(10 years ago)

US5747642 LILLY Monomeric insulin analog formulations
Jun, 2014

(10 years ago)




Market Authorisation Date: 22 December, 1999

Treatment: Use for the treatment of hyperglycemia; Treatment of diabetes mellitus

Dosage: INJECTABLE

More Information on Dosage

HUMALOG MIX 50/50 family patents

Family Patents

2. Humalog Mix 50/50 Kwikpen patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5514646 LILLY Insulin analogs modified at position 29 of the B chain
May, 2013

(11 years ago)

US5747642 LILLY Monomeric insulin analog formulations
Jun, 2014

(10 years ago)

US5474978 LILLY Insulin analog formulations
Jun, 2014

(10 years ago)

US5461031 LILLY Monomeric insulin analog formulations
Jun, 2014

(10 years ago)

US7291132 LILLY Medication dispensing apparatus with triple screw threads for mechanical advantage
Aug, 2024

(25 days from now)




Market Authorisation Date: 22 December, 1999

Treatment: Use for the treatment of hyperglycemia; Treatment of diabetes mellitus

Dosage: INJECTABLE

More Information on Dosage

HUMALOG MIX 50/50 KWIKPEN family patents

Family Patents

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

3. Humalog Mix 75/25 patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5514646 LILLY Insulin analogs modified at position 29 of the B chain
May, 2013

(11 years ago)

US5461031 LILLY Monomeric insulin analog formulations
Jun, 2014

(10 years ago)

US5747642 LILLY Monomeric insulin analog formulations
Jun, 2014

(10 years ago)

US5474978 LILLY Insulin analog formulations
Jun, 2014

(10 years ago)




Market Authorisation Date: 22 December, 1999

Treatment: Use for the treatment of hyperglycemia; Treatment of diabetes mellitus

Dosage: INJECTABLE

More Information on Dosage

HUMALOG MIX 75/25 family patents

Family Patents

4. Humalog Mix 75/25 Kwikpen patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5514646 LILLY Insulin analogs modified at position 29 of the B chain
May, 2013

(11 years ago)

US5747642 LILLY Monomeric insulin analog formulations
Jun, 2014

(10 years ago)

US5461031 LILLY Monomeric insulin analog formulations
Jun, 2014

(10 years ago)

US5474978 LILLY Insulin analog formulations
Jun, 2014

(10 years ago)

US7291132 LILLY Medication dispensing apparatus with triple screw threads for mechanical advantage
Aug, 2024

(25 days from now)




Market Authorisation Date: 22 December, 1999

Treatment: Use for the treatment of hyperglycemia; Treatment of diabetes mellitus

Dosage: INJECTABLE

More Information on Dosage

HUMALOG MIX 75/25 KWIKPEN family patents

Family Patents